Health · 1 views
Despite Medicare coverage, many cancer patients still do not receive testing that guides treatment options
While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the most effectiv…
AI Summary
While there has been a recent increase among Medicare recipients in genomic testing that helps match cancer patients to the most effective treatment for their tumor, many Medicare beneficiaries with cancer are still not receiving next-generation sequencing (NGS), according to a new analysis by Georgetown University researchers.
Read full article on MedicalxpressAI summaries can be wrong sometimes—always verify important details using the source article.
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Health
Continue reading recent Health coverage
- Researchers discover pathway that makes glioblastoma cells vulnerable to treatmentContinue reading
- Cholera still kills thousands each year. In places without clean water, it's far from historyContinue reading
- A skill becomes automatic as the brain rewires itself to bypass its own bottleneck, new study suggestsContinue reading